Paxlovid and Gemcitabine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Paxlovid (nirmatrelvir; ritonavir) and Gemcitabine (gemcitabine). Common drug interactions include colitis among females and cardiac failure among males.
The phase IV clinical study analyzes what interactions people have when they take Paxlovid and Gemcitabine. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Paxlovid?
Paxlovid has active ingredients of nirmatrelvir; ritonavir. eHealthMe is studying from 38,421 Paxlovid users. Check the latest studies of Paxlovid.
What is Gemcitabine?
Gemcitabine has active ingredients of gemcitabine. eHealthMe is studying from 31,337 Gemcitabine users. Check the latest studies of Gemcitabine.
22 people who take Paxlovid and Gemcitabine together, and have interactions are studied.

What are the common drug interactions of Paxlovid and Gemcitabine, by gender? *:
female:
- Colitis (inflammation of colon)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
male:
- Cardiac failure
- Febrile neutropenia (fever with reduced white blood cells)
- Aspergillus test positive
- Disease progression
- Dysgeusia (disorder of the sense of taste)
- Pruritus (severe itching of the skin)
- Tumour flare (temporary increase in symptoms from a cancer after starting treatment)
- Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
What are the common drug interactions of Paxlovid and Gemcitabine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Dysgeusia (disorder of the sense of taste)
- Pruritus (severe itching of the skin)
50-59:
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Cardiac failure
- Tumour flare (temporary increase in symptoms from a cancer after starting treatment)
60+:
- Febrile neutropenia (fever with reduced white blood cells)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Colitis (inflammation of colon)
What are the existing conditions these people have? *
- Burkitt Lymphoma (cancer of the lymphatic system): 8 people, 36.36%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 22.73%
- Lung Disorder (lung disease): 4 people, 18.18%
- Nausea (feeling of having an urge to vomit): 2 people, 9.09%
- Joint Swelling: 2 people, 9.09%
- Joint Pain: 2 people, 9.09%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 9.09%
- High Blood Pressure: 2 people, 9.09%
- Cardiac Failure: 2 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Paxlovid and Gemcitabine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Paxlovid (38,421 reports)
- Gemcitabine (31,337 reports)
Browse all drug interactions of Paxlovid and Gemcitabine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Paxlovid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Gemcitabine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Paxlovid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gemcitabine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Alam, S., Illo, C., Ma, Y. T., & Punia, P. , "Gemcitabine-induced cardiotoxicity in patients receiving adjuvant chemotherapy for pancreatic cancer: a case series", Case reports in oncology, 2018 Jan .
- Alam, S., Illo, C., Ma, Y. T., & Punia, P. , "Gemcitabine-induced cardiotoxicity in patients receiving adjuvant chemotherapy for pancreatic cancer: a case series", Case reports in oncology, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on nirmatrelvir; ritonavir and gemcitabine (the active ingredients of Paxlovid and Gemcitabine, respectively), and Paxlovid and Gemcitabine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Divalproex Sodium cause Cerebellar Atrophy? - a second ago
- Drug interactions of Indapamide and Methylprednisolone - 2 seconds ago
- Joint Pain and Pharyngeal Erythema - 8 seconds ago
- Drug interactions of Entresto and Tyvaso - 26 seconds ago
- Could Caffeine cause Heart Attack? - 28 seconds ago
- Could Dexamethasone Acetate cause Pneumonia Aggravated? - 31 seconds ago
- Could Revlimid cause Insomnia? - 37 seconds ago
- Could Movantik cause Abdominal Pain Upper? - 37 seconds ago
- Could Diphen cause Administration Site Pain? - 44 seconds ago
- Could Profen cause Laryngeal Nerve Damage? - 52 seconds ago